Showing results (1-10 of 101) with videos related to
Sort By:
Pageof 11
Hematology/Oncology Clinics of North America|February 25, 2020
Novel Prognostic Models for Myelodysplastic SyndromesJacob Shreve, Aziz NazhaClinical Hematology International|September 4, 2020
The Evolving Landscape of Myelodysplastic Syndrome PrognosticationJacob Shreve, Aziz NazhaMayo Clinic Proceedings. Innovations, Quality & Outcomes|May 18, 2021
Personalized Prediction of Hospital Mortality in COVID-19-Positive PatientsDaniel Rozenbaum, Jacob Shreve, Nathan Radakovich, et al.Best Practice & Research. Clinical Haematology|November 30, 2019
Does mutational burden add to other prognostic factors in MDS?Aziz NazhaHematology. American Society of Hematology. Education Program|December 4, 2018
The MDS genomics-prognosis symbiosisAziz NazhaCurrent Hematologic Malignancy Reports|November 24, 2023
Unlocking the Potential of Artificial Intelligence in Acute Myeloid Leukemia and Myelodysplastic SyndromesAbdulrahman Alhajahjeh, Aziz NazhaCurrent Hematologic Malignancy Reports|October 12, 2018
Online and Social Media Resources for Patients with MDSNour Abuhadra, Aziz NazhaLeukemia & Lymphoma|July 27, 2013
Acute myeloid leukemia in the elderly: do we know who should be treated and how?Aziz Nazha, Farhad RavandiCurrent Hematologic Malignancy Reports|August 28, 2017
Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDSAziz Nazha, Rafael BejarCurrent Hematologic Malignancy Reports|August 10, 2016
Improving Prognostic Modeling in Myelodysplastic SyndromesAziz Nazha, Mikkael A SekeresPageof 11